Open AccessEffect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-β1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C
Author(s) -
Robert Flisiak,
Jerzy Jaroszewicz,
Tadeusz Wojciech Łapiński,
Iwona Flisiak,
Danuta Prokopowiczi
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i43.6833
Subject(s) - ribavirin , medicine , tissue inhibitor of metalloproteinase , pegylated interferon , gastroenterology , alpha interferon , biomarker , chronic hepatitis , endocrinology , interferon , matrix metalloproteinase , immunology , chemistry , virus , biochemistry
To evaluate the effect of antiviral treatment on plasma levels of transforming growth factor-beta1 (TGF-beta1), metalloproteinase 1 (MMP-1), and tissue inhibitor of metalloproteinase-1 (TIMP-1) in patients with chronic hepatitis C.